Current perspectives on the diagnosis and treatment of major depressive disorder

American Journal of Managed Care

Volumn 7, Issue 11 SUPPL., 2001, Pages

  Nierenberg, A A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMITRIPTYLINE PLUS PERPHENAZINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOPAMINE UPTAKE INHIBITOR; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; ISOCARBOXAZID; MAPROTILINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; UNINDEXED DRUG; VENLAFAXINE;

CLINICAL FEATURE; COST OF ILLNESS; DEPRESSION; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; HUMAN; PRIORITY JOURNAL; PROGNOSIS; PSYCHOTHERAPY; REVIEW;

ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DRUG UTILIZATION REVIEW; HEALTH BENEFIT PLANS, EMPLOYEE; HUMANS; PROGNOSIS; PSYCHOTHERAPY; UNITED STATES; WORKPLACE;

EID: 0034800021     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Antidepressant utilization patterns in a national managed care organization
2. Psychiatric disorder in medical in-patients
3. Documentation of indicators for antidepressant treatment and response in an HMO primary care population
4. Recognizing and treating depression in outpatients with diabetes
5. Access and utilization of new antidepressants and antipsychotic medications
6. Depression in adults
7. Medical comorbidity of major depressive disorder in a primary medical practice
8. Disability and depression among high utilizers of health care: A longitudinal analysis
9. Health care costs of primary care patients with recognized depression
10. Life events and endogenous depression: A puzzle reexamined
11. The depressed alcoholic: Clinical features and medical management
12. Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression
13. A neuropsychiatric program for HIV-infected individuals
14. Long-term treatment of depression
15. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence
16. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression
17. Sequenced treatment alternatives to relieve depression
18. Pharmacoeconomic studies of antidepressants: Focus on venlafaxine
19. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination
20. How antidepressants work: New perspectives on the pathophysiology of depressive disorder
21. Cost-effectiveness of venlafaxine for the treatment of major depression in hospitalized patients
22. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission
23. Update on electroconvulsive therapy (ECT) in older adults
24. The prevalence and distribution of major depression in a natural community sample: The National Comorbidity Survey
25. Lightening the load of major depression
26. Carving in and keeping mental health care in the managed care setting
27. The functioning and well-being of depressed patients. Results from the Medical Outcomes study
28. Randomized trial of a depression management program in high utilizers of medical care
29. Major depression in primary care practice: Clinical characteristics and treatment implications
30. Persistently poor outcomes of undetected major depression in primary care
31. Management of depression in the outpatient office
32. Co-occurrence of depression with heart disease
33. Co-occurrence of depression with stroke
34. The unrecognized link: Depression co-occurring with medical conditions
35. Co-occurrence of depression with cancer
36. Co-occurrence of depression with medical, psychiatric, and substance abuse disorders
37. Depression following myocardial infarction. Impact on 6-month survival
38. The impact of depressive symptomatology on physical disability: MacArthur studies of successful aging
39. Depressive symptoms, satisfaction with health care, and 2-year work outcomes in an employed population
40. Health and disability costs of depressive illness in a major U.S. corporation
41. Recovery from depression, work productivity, and health care costs among primary care patients
42. National results for selected 2000 HEDIS and HEDIS/CAHPS measures: Antidepressant medication management